7729.TWO
Price:
$42.35
Market Cap:
$2.82B
Steminent Biotherapeutics, Inc. develops novel cellular therapeutics and engages in the research and development of new stem cell drugs. Its products include stemchymal, stemchymal therapeutic advantages and stemchymal application fields. The company was founded on December 18, 2007 and is headquartered in Taipei, Taiwan.
Industry
Biotechnology
IPO Date
2024-03-11
Stock Exchange
TWO
Ticker
7729.TWO
According to Steminent Biotherapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -50.04%. This represents a change of 241.28% compared to the average of -14.66% of the last 4 quarters.
The mean historical ROE of Steminent Biotherapeutics Inc. over the last ten years is 50.22%. The current -50.04% ROE has changed -199.64% with respect to the historical average. Over the past ten years (40 quarters), 7729.TWO's ROE was at its highest in in the December 2022 quarter at 0%. The ROE was at its lowest in in the December 2024 quarter at -21.19%.
Average
50.22%
Median
-44.76%
Minimum
-52.27%
Maximum
425.18%
Discovering the peaks and valleys of Steminent Biotherapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.74%
Maximum Annual ROE = 425.18%
Minimum Annual Increase = -111.96%
Minimum Annual ROE = -52.27%
| Year | ROE | Change |
|---|---|---|
| 2024 | -44.76% | 70.74% |
| 2023 | -26.21% | -49.85% |
| 2022 | -52.27% | 2.79% |
| 2021 | -50.85% | -111.96% |
The current ROE of Steminent Biotherapeutics Inc. (7729.TWO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-41.08%
5-year avg
50.22%
10-year avg
50.22%
Steminent Biotherapeutics Inc.’s ROE is greater than TaiRx, Inc. (-23.22%), greater than Gwo Xi Stem Cell Applied Technology Co. , Ltd (-10.90%), greater than GlycoNex Incorporation (-19.51%), greater than Intech Biopharm Corporation (-35.97%), greater than Taiwan Bio Therapeutics Co., Ltd (-42.93%), greater than Anti-Microbial Savior BioteQ Co., Ltd (-41.50%), less than HeXun Biosciences Co., Ltd. (25.45%), greater than Hcmed (-68.42%), greater than Sinew Pharma Inc. (-12.12%), greater than Sunny Pharmtech Inc. (-27.76%),
| Company | ROE | Market cap |
|---|---|---|
| -23.22% | $2.54B | |
| -10.90% | $2.70B | |
| -19.51% | $2.33B | |
| -35.97% | $2.46B | |
| -42.93% | $2.29B | |
| -41.50% | $2.62B | |
| 25.45% | $2.56B | |
| -68.42% | $2.29B | |
| -12.12% | $2.77B | |
| -27.76% | $2.10B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Steminent Biotherapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Steminent Biotherapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Steminent Biotherapeutics Inc.'s ROE?
How is the ROE calculated for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the highest ROE for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the 3-year average ROE for Steminent Biotherapeutics Inc. (7729.TWO)?
What is the 5-year average ROE for Steminent Biotherapeutics Inc. (7729.TWO)?
How does the current ROE for Steminent Biotherapeutics Inc. (7729.TWO) compare to its historical average?